Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Issue title: The Fifth Conference of the International CoQ10 Association, Kobe 2007 – 50th anniversary of CoQ10 discovery
Article type: Research Article
Authors: Morré, Dorothy M. | Morré, D. James | Rehmus, Wingfield | Kern, Dale
Affiliations: Department of Foods and Nutrition, Purdue University, West Lafayette, IN, USA | Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN, USA | Stanford University, Palo Alto, CA, USA | NSE Products and Pharmanex, Provo, UT, USA
Note: [] Address for correspondence: Dorothy M. Morré, Department of Foods and Nutrition, Purdue University, 700 W. State St., West Lafayette, IN 47907-2059, USA. E-mail: [email protected]
Abstract: Our work has identified an aging-related ECTO-NOX activity (arNOX), a hydroquinone oxidase which is cell surface located and generates superoxide. This activity increases with increasing age beginning >30 y. Because of its cell surface location and ability to generate superoxide, the arNOX proteins may serve to propagate an aging cascade both to adjacent cells and to oxidize circulating lipoproteins as significant factors determining atherogenic risk. The generation of superoxide by arNOX proteins is inhibited by Coenzyme Q_{10} as one basis for an anti-aging benefit of CoQ_{10} supplementation in human subjects. In a preliminary pilot study, 25 female subjects between 45 and 55 y of age were recruited at Stanford University from the Palo Alto, CA area. Informed consent was obtained. Ten of the subjects received Coenzyme Q_{10} supplementation of 180 (3 × 60 mg) per day for 28 days. Serum, saliva and perspiration levels of arNOX were determined at 7, 14 and 28 days of CoQ_{10} supplementation and compared to the initial baseline value. Activity correlated with subject age up to a maximum between age 50 and 55 years of age for saliva and perspiration as well and then declined. With all three sources, the arNOX activity extrapolated to zero at about age 30. Response to Coenzyme Q_{10} also increased with age being least between ages 45 and 50 and greatest between ages 60 and 65. With all three biofluids, arNOX activity was reduced between 25 and 30% by a 3 × 60 mg daily dose Coenzyme Q_{10} supplementation. Inhibition was the result of Coenzyme Q_{10} presence.
Journal: BioFactors, vol. 32, no. 1-4, pp. 221-230, 2008
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]